Eastern Bank purchased a new position in shares of Koninklijke Philips (NYSE:PHG – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,689 shares of the technology company’s stock, valued at approximately $88,000.
Other institutional investors have also made changes to their positions in the company. Allspring Global Investments Holdings LLC acquired a new stake in shares of Koninklijke Philips during the first quarter worth approximately $40,000. Fairscale Capital LLC acquired a new stake in Koninklijke Philips in the second quarter valued at approximately $54,000. CWM LLC lifted its stake in Koninklijke Philips by 21.9% in the second quarter. CWM LLC now owns 3,429 shares of the technology company’s stock valued at $86,000 after acquiring an additional 616 shares during the last quarter. Blue Trust Inc. lifted its stake in Koninklijke Philips by 902.7% in the second quarter. Blue Trust Inc. now owns 3,700 shares of the technology company’s stock valued at $93,000 after acquiring an additional 3,331 shares during the last quarter. Finally, Headlands Technologies LLC acquired a new stake in Koninklijke Philips in the first quarter valued at approximately $91,000. 13.67% of the stock is currently owned by institutional investors and hedge funds.
Koninklijke Philips Price Performance
Shares of Koninklijke Philips stock opened at $31.67 on Friday. The firm has a fifty day simple moving average of $31.05 and a 200-day simple moving average of $27.61. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60. Koninklijke Philips has a 1-year low of $18.06 and a 1-year high of $32.91. The stock has a market capitalization of $29.77 billion, a price-to-earnings ratio of -59.75, a PEG ratio of 1.05 and a beta of 0.74.
Analysts Set New Price Targets
Separately, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Monday, July 15th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, Koninklijke Philips presently has a consensus rating of “Hold”.
Koninklijke Philips Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
- Five stocks we like better than Koninklijke Philips
- The Significance of Brokerage Rankings in Stock Selection
- Texas Roadhouse Stock Steering for New Highs This Year
- When to Sell a Stock for Profit or Loss
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- ESG Stocks, What Investors Should Know
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Free Report).
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.